Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
37.45
-0.17 (-0.45%)
At close: Feb 27, 2026, 4:00 PM EST
37.49
+0.04 (0.10%)
After-hours: Feb 27, 2026, 7:59 PM EST
Novo Nordisk Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Novo Nordisk stock have an average target of 54.25, with a low estimate of 46 and a high estimate of 70. The average target predicts an increase of 44.86% from the current stock price of 37.45.
Analyst Consensus: Hold
* Price targets were last updated on Nov 28, 2025.
Analyst Ratings
The average analyst rating for Novo Nordisk stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 4 | 5 | 5 | 6 |
| Sell | 1 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 24, 2026 |
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $60 → $54 | Strong Buy | Maintains | $60 → $54 | +44.19% | Nov 28, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $50 → $46 | Hold | Maintains | $50 → $46 | +22.83% | Nov 25, 2025 |
| HSBC | HSBC | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 24, 2025 |
Financial Forecast
Revenue This Year
299.23B
from 309.06B
Decreased by -3.18%
Revenue Next Year
312.37B
from 299.23B
Increased by 4.39%
EPS This Year
22.78
from 23.03
Decreased by -1.09%
EPS Next Year
24.20
from 22.78
Increased by 6.22%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 368.7B | 386.0B | |||
| Avg | 299.2B | 312.4B | |||
| Low | 264.3B | 258.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.3% | 29.0% | |||
| Avg | -3.2% | 4.4% | |||
| Low | -14.5% | -13.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 29.09 | 31.63 | |||
| Avg | 22.78 | 24.20 | |||
| Low | 19.89 | 19.91 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 26.3% | 38.8% | |||
| Avg | -1.1% | 6.2% | |||
| Low | -13.6% | -12.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.